The Food and Drug Administration (FDA) approves a new biologic treatment to treat ulcerative colitis. Manufacturer Centocor, Inc. announces that Remicade has received the green light to treat the chronic inflammatory bowel disease.

Remicade's efficiency in the treatment of inflammatory bowel disease is well established. It was first approved in the United States for the treatment of Crohn's disease in 1998.Remicade remains to this day the only anti-tumor necrosis factor therapy indicated for the treatment of Chron's. With this new approval for the treatment of ulcerative colitis, Remicade is now the only biologic indicated for the treatment of both types of inflammatory bowel diseases

The Food and Drug Administration (FDA) approves a new biologic treatment to treat ulcerative colitis. Manufacturer Centocor, Inc. announces that Remicade has received the green light to treat the chronic inflammatory bowel disease.

Remicade's efficiency in the treatment of inflammatory bowel disease is well established. It was first approved in the United States for the treatment of Crohn's disease in 1998.Remicade remains to this day the only anti-tumor necrosis factor therapy indicated for the treatment of Chron's. With this new approval for the treatment of ulcerative colitis, Remicade is now the only biologic indicated for the treatment of both types of inflammatory bowel diseases

A new study of heart patients shows that putting a small, drug-coated metal tube, or stent, inside the blood vessels can reduce the need for major surgery or other procedures. Each year, about 1 million Americans are treated for blocked heart vessels that prevent blood from flowing the way it should.

The stents are coated with a drug called Paclitaxel, which prevents scar tissue from growing and re-clogging the artery

A baby born last month to an unconscious, severely brain-damaged northern Virginia woman has died at the age of five weeks.

In a statement, the Torres family says that Susan Anne Catherine Torres died of heart failure Sunday night after emergency surgery to repair a perforated intestine

The urinary incontinence that often follows prostate surgery can be improved with injections of collagen into the area of the urinary sphincter, according to a new study.

"Collagen is suitable in patients who do not wish a more invasive option," Dr. O. Lenaine Westney from the University of Texas Houston Health Science Center told Reuters Health